Promotoras for Cancer Survivorship-Redes/LAF |
Eliseo Perez-Stable, MD |
Cancer/Oncology |
|
|
The Breast and Cervical Cancer Care Coordination and Navigation Program |
Claire Brindis, DrPH |
Cancer/Oncology, Women's Health |
|
|
Women and Infants Transmission Study - Human Papillomavirus Protocol |
Joel Palefsky, MD |
Infectious Disease, HIV/AIDS, Cancer/Oncology, Women's Health |
|
|
HPV and AIDS Malignancies Clinical Trials Consortium (AMC) |
Joel Palefsky, MD |
HIV/AIDS, Cancer/Oncology |
|
|
SMART Anal Dysplasia Sub-Study |
Joel Palefsky, MD |
HIV/AIDS, Opportunistic Infection, Cancer/Oncology |
|
|
Redes En Accion: National Latino Cancer Research Network |
Eliseo Perez-Stable, MD |
Cancer/Oncology, Immigration and Migration, Engagement in Care |
|
|
Exploring Early Detection Methods: Using the Intraductal Approach to Predict Breast Cancer |
Kimberly Baltzell, RN, PhD, MS |
Cancer/Oncology, Women's Health |
|
|
Psychosocial Support Services for Latinas with Breast Cancer |
Anna Napoles, PhD, MPH |
Cancer/Oncology, Neurology and Mental Health, Women's Health |
|
|
Active Surveillance for Early Stage Prostate Cancer: Selection, Monitoring |
Peter Carroll, MD |
Cancer/Oncology |
|
|
Filipina Breast Cancer Support: Which Model is Meaningful? [2] |
Nancy Burke, PhD |
Cancer/Oncology |
|
|
Herpesviral Gene Expression in Kaposi's Sarcoma |
Donald E. Ganem, MD |
HIV/AIDS, Cancer/Oncology, Genetics |
|
|
Sinag Tala (Bright Star): Pilipina Breast Cancer Support Group Outreach |
Nancy Burke, PhD |
Cancer/Oncology |
|
|
Mechanisms of Bartonella Virulence in AIDS Patients |
Jane Koehler, MD |
HIV/AIDS, Cancer/Oncology, Risk Reduction and Prevention |
|
|
Anal Human Papillomavirus (HPV) in Methamphetamine (MA) Using and Non-Using Men Who Have Sex with Men (MSM) in Los Angeles |
Joel Palefsky, MD |
Infectious Disease, Cancer/Oncology, Substance Abuse, Risk Reduction and Prevention |
|
|
California Division Special Research Scholar Grant in HIV-Related Cancers |
Joel Palefsky, MD |
HIV/AIDS, Cancer/Oncology |
|
|
A Phase II Clinical Trial of Pembrolizumab as Monotherapy for Metastatic Triple-Negative Breast Cancer (mTNBC) |
Hope Rugo, MD |
Cancer/Oncology |
|
|
HPV-Specific T Cell Responses and Anogenital HPV Disease in Women of the WIHS |
Malcolm John, MD |
HIV/AIDS, Cancer/Oncology, Women's Health |
|
|
Test characteristics of nipple aspirate fluid cytology for the prediction of breast cancer |
Jeffrey Tice, MD |
Cancer/Oncology, Women's Health |
|
|
Affinity Isolation of Direct Kinase Substrates |
Kevan Shokat, PhD |
Cancer/Oncology |
|
|
Molecular Effects of Nutrition Supplements in Prostate |
Peter Carroll, MD |
Cancer/Oncology |
|
|
Biochemistry and Hepatic Toxicity of Carbon Radicals |
Paul Ortiz De Montellano, PhD |
Cancer/Oncology |
|
|
Doris Duke Charitable Foundation International Clinical Research Fellowship Program |
Joel Palefsky, MD |
HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Oral Health, Neurology and Mental Health, Women's Health, Pediatrics, Newborn and Infant Health, Immigration and Migration, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training |
|
|
A Study Investigating the Association of HPV-Related Biomarkers with the Detection of Anal Precancer And Cancer in HIV-Positive Men Who Have Sex with Men (MSM) |
Teresa Darragh, MD |
HIV/AIDS, Cancer/Oncology |
|
|
Merck Drug Donation for Antiretroviral Therapy of AIDS-Related Kaposi Sarcoma in Africa |
Jeffrey Martin, MD, MPH |
HIV/AIDS, Cancer/Oncology |
|
|
Admixture Mapping for Breast Cancer Subtypes Among African American Women |
Laura Fejerman, PhD |
Cancer/Oncology, Women's Health |
|
|
The Cancer Genome Atlas (TCGA) Pilot Program |
Karen Smith-McCune, MD, PhD |
Cancer/Oncology, Systematic Reviews and Guideline Development |
|
|
Effects of the Chornobyl Accident on Thyroid Cancer and Leukemia & Related Diseases (NO1-CP-21178) |
Lydia Zablotska, MD, MPA, PhD |
Cancer/Oncology, Occupational and Environmental Disease |
|
|
UCSF Prostate Cancer SPORE |
Peter Carroll, MD |
Cancer/Oncology |
|
|
UCSF-Kaiser Building Interdisciplinary Research Careers in Women's Health Program |
Ruth Greenblatt, MD |
HIV/AIDS, Noncommunicable and/or Chronic Disease, Cancer/Oncology, Cardiovascular Disease, Diet, Exercise, and Obesity, Dementia and Cognitive Impairment, Women's Health, UCSF Professional Education |
|
|
A Workshop on Applications of Mechanistic Information in Human Health Risk Assessment |
Tracey Woodruff, PhD, MPH |
Cancer/Oncology, Occupational and Environmental Disease |
|
|
A Master Agreement: HPV Testing of Samples from the AIDS Malignancy Consortium |
Joel Palefsky, MD |
HIV/AIDS, Cancer/Oncology, Women's Health |
|
|
Cidofovir for Perianal Dysplasia in HIV Patients |
Joel Palefsky, MD |
HIV/AIDS, Cancer/Oncology |
|
|
Immunosenescence Profiles of Atypical Cases of Kaposi Sarcoma in Well-Controlled HIV Infection |
Toby Maurer, MD |
HIV/AIDS, Cancer/Oncology |
|
|
Biomarkers that Predict the Response of AIDS-Related Kaposi's Sarcoma to Antiretroviral Therapy and the Risk of Developing Immune Reconstitution Inflammatory Syndrome |
|
HIV/AIDS, Cancer/Oncology |
|
|
Immunoprotective Effects of Lopinavir/Ritonavir in HIV-Infected Patients in Sub-Saharan Africa |
Jeffrey Martin, MD, MPH |
HIV/AIDS, Cancer/Oncology |
|
|
Viruses in Breast Fluid: Biomarkers for Breast Cancer? |
Kimberly Baltzell, RN, PhD, MS |
Cancer/Oncology, Drug and Diagnostics Development, Women's Health |
|
|
Communicating about Clinical Trials: Bringing the Cancer Information Service (CIS) to the Underserved [II] |
Nancy Burke, PhD |
Cancer/Oncology, Patient and Peer Education |
|
|
Bay Area Breast Cancer and Environment Research Center |
Robert Hiatt, MD, PhD |
Cancer/Oncology, Women's Health |
|
|
Filipina Breast Cancer Support: What Model is Meaningful? [1] |
Nancy Burke, PhD |
Cancer/Oncology |
|
|
Texas Children’s Hospital Global Health Service Corps |
Anu Agrawal, MD |
Cancer/Oncology, Pediatrics |
|
|
Pediatric Kaposi Sarcoma, Botswana 2012 HIV Clinical Management Guidelines |
Anu Agrawal, MD |
HIV/AIDS, Cancer/Oncology, Pediatrics |
|
|
Antiretroviral Therapy of AIDS-Related Kaposi's Sarcoma in Africa |
Jeffrey Martin, MD, MPH |
HIV/AIDS, Cancer/Oncology |
|
|
Bay Area Breast Cancer and the Environment Research Center |
Robert Hiatt, MD, PhD |
Cancer/Oncology, Occupational and Environmental Disease |
|
|
NAAccord (CHK-UP on HIV Supplement) |
Jeffrey Martin, MD, MPH |
HIV/AIDS, Noncommunicable and/or Chronic Disease, Cancer/Oncology, Cardiovascular Disease |
|
|
To Discover and Characterize Novel Viruses in Cancer |
Charles Chiu, MD, PhD |
Infectious Disease, Cancer/Oncology |
|
|
Determinants of Participation in an Anal Cancer Prevention Trial |
Joel Palefsky, MD |
Cancer/Oncology |
|
|
Partnership to Advance Breast Cancer Research |
Tracey Woodruff, PhD, MPH |
Cancer/Oncology, Occupational and Environmental Disease, Women's Health |
|
|
Phase II Study of 7 Days On/7 Days Off Temozolomide in Patients with High Grade Glioma |
Nicholas Butowski, MD |
Cancer/Oncology, Pharmacology and Drug Treatment |
|
|
Abbott Drug Donation for Antiretroviral Therapy of AIDS-Related Kaposi's Sarcoma in Africa |
Jeffrey Martin, MD, MPH |
HIV/AIDS, Cancer/Oncology |
|
|
Probe Development for Prostate Cancer |
Henry Vanbrocklin, PhD |
Cancer/Oncology |
|
|
Clinical Trials Education and Access for Underserved Women |
Galen Joseph, PhD |
Cancer/Oncology, Patient and Peer Education |
|
|
Noninvasive Identifiers of Women with High Breast Density |
John Shepherd, PhD |
Cancer/Oncology, Women's Health |
|
|
Paternal Smoking and DNA Methylation in Childhood Leukemia |
Joseph Wiemels, PhD |
Cancer/Oncology, Pediatrics, Smoking and Tobacco |
|
|
Epidemiologic Effects of ART on HIV-related Anal Cancer and Anal Dysplasia |
Joel Palefsky, MD |
Infectious Disease, HIV/AIDS, Cancer/Oncology |
|
|
Athena Breast Care Network |
Laura Esserman, MD |
Cancer/Oncology, Women's Health |
|
|
Cervical Cancer Screening with a Novel Biomarker in HIV-Infected Women |
Megan Huchko, MD |
HIV/AIDS, Cancer/Oncology |
|
|
Nuevo Amanecer: Promoting the Psychosocial Health of Latinas |
Anna Napoles, PhD, MPH |
Cancer/Oncology, Neurology and Mental Health, Women's Health |
|
|
Taste for the Cure and a Taste of Science |
Laura Esserman, MD |
Cancer/Oncology, Women's Health |
|
|
New treatments for triple negative breast cancer through the biparatopic inhibition of the uPAR receptor |
|
Cancer/Oncology |
|
|
6th International Workshop on Breast Cancer Risk Assessment |
John Shepherd, PhD |
Cancer/Oncology, Women's Health |
|
|
Pharmacogenetics of Chemotherapy-Induced Toxicity in Breast Cancer |
Deanna Kroetz, PhD |
Cancer/Oncology, Genetics, Pharmacology and Drug Treatment, Women's Health |
|
|
Alex's Lemonade Stand Foundation Post Program |
Katherine Matthay, MD |
Cancer/Oncology, Pediatrics |
|
|
St. Baldrick's Summer Fellowship |
Michelle Hermiston, MD, PhD |
Cancer/Oncology, Pediatrics, Risk Reduction and Prevention |
|
|
Development of Targeted Anti-Cancer Platinum Analogs |
Kathleen Giacomini, PhD |
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Open-Label, Expanded Access Protocol of BSI-201 in Combination with Gemcitabine/Carboplatin in Patients with ER-, PR-, and HER2-Negative Metastatic Breast Cancer |
Hope Rugo, MD |
Cancer/Oncology, Women's Health |
|
|
Early Detection of Metastasis-Prone Breast Cancers |
Laura Esserman, MD |
Cancer/Oncology, Drug and Diagnostics Development, Women's Health |
|
|
Role of Metalloproteinases in Mammary Gland Remodeling |
Zena Werb, PhD |
Cancer/Oncology |
|
|
Children's Oncology Group Acute Lymphoblastic Leukemia High Risk Molecular Markers |
Mignon Loh, MD |
Cancer/Oncology |
|
|
Buong Puso: Linking Filipinas with Breast Cancer to Care and Support Resources |
Nancy Burke, PhD |
Cancer/Oncology |
|
|
Genome-Wide Predictors of Treatment-Related Toxicities |
Deanna Kroetz, PhD |
Cancer/Oncology, Women's Health |
|
|
Sanofi-Aventis SAR650894 Program - Clinical Component |
Thomas Martin, MD |
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Sanofi-Aventis SAR650894 Program - Research Component |
Thomas Martin, MD |
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Colorectal Cancer Screening with FIT during Annual Flu Shot Clinics |
Michael Potter, MD |
Cancer/Oncology, Engagement in Care, Patient and Peer Education |
|
|
Prevention and Treatment of Impotence |
Tom Lue, MD |
Cancer/Oncology, Risk Reduction and Prevention |
|
|
Adult Brain Tumor Consortium (ABTC) |
Michael Prados, MD |
Cancer/Oncology |
|
|
Adjuvant Treatment with Temodar plus Avastin Alone or with Tarceva in Patient with Newly Diagnosed Glioblastoma Multiforme Who Are Stable Following Radiotherapy with Temodar |
Michael Prados, MD |
Cancer/Oncology, Pharmacology and Drug Treatment |
|
|
Cellular and Genetic Origins of Astrocytes |
David Rowitch, MD, PhD |
Noncommunicable and/or Chronic Disease, Cancer/Oncology, Neurology and Mental Health, Risk Reduction and Prevention |
|
|
Reducing Disparities in Colorectal Cancer Screening in Vietnamese Americans |
Tung Nguyen, MD |
Cancer/Oncology |
|
|
Pre-B Cell Receptor Signaling in Acute Lymphoblastic Leukemia |
Markus Muschen, MD, PhD |
Cancer/Oncology |
|
|
Breast Cancer Risk Reduction in Primary Care Clinics: A Bilingual Intervention for Women and Physicians |
Celia Kaplan, DrPH |
Cancer/Oncology, Women's Health |
|
|
Individually Optimized Conditioning Using PK-directed Dose Adjustment of Once Daily IV Busulfan, Followed by Autologous Hematopoietic Stem Cell Transplant |
Ai Weiyun, MD, PhD |
Cancer/Oncology, Pharmacology and Drug Treatment |
|
|
Metabolic Imaging of the Prostate Using 3-D MRSI |
Daniel Vigneron, PhD |
Cancer/Oncology, Risk Reduction and Prevention |
|
|
HIV and HPV Transmission Across Mucosal Epithelia |
Sharof Tugizov, PhD |
HIV/AIDS, Cancer/Oncology |
|
|
The Kit Signaling Pathway As a Therapeutic Target in Melanoma |
Boris Bastian, MD, PhD |
Cancer/Oncology |
|
|
Kaposi Sarcoma Subgroup of WHO Guidelines Development Group for HIV-Associated Skin and Oral Conditions |
Anu Agrawal, MD |
HIV/AIDS, Cancer/Oncology, Pediatrics |
|
|
Genetic Analysis of the Nucleosome and RNA Polymerase II: a Systems Approach |
Nevan Krogan, PhD, MSc |
Noncommunicable and/or Chronic Disease, Cancer/Oncology, Genetics |
|
|
Transcriptional Regulation of Breast Cancer Metastasis |
Zena Werb, PhD |
Cancer/Oncology, Women's Health |
|
|
Research and Evaluation of the Virtual Symposium on Radiation Safety in Computed Tomography (CT) |
Rebecca Smith-Bindman, MD |
Cancer/Oncology, Epidemiology and Surveillance, Risk Reduction and Prevention |
|
|
Anal Cytology/HPV Testing Study |
Joel Palefsky, MD |
Infectious Disease, Cancer/Oncology, Systematic Reviews and Guideline Development |
|
|
Promotoras for Cancer Survivorship-Redes/LAF |
Eliseo Perez-Stable, MD |
Cancer/Oncology, Women's Health |
|
|
The Role of Microenvironment-Mediated CXCR4/CXCL12 Axis in Inducing Chemoresistance in Pediatric T-Cell Acute Lymphoblastic Leukemia |
Michelle Hermiston, MD, PhD |
Cancer/Oncology, Pediatrics |
|
|
Admixture Mapping for Breast Cancer in Latinas |
Elad Ziv, MD |
Cancer/Oncology, Women's Health |
|
|
Phase I Parallel Protocol of MK-8669 (Ridaforolimus) + MK-2206 and MK-8669 (Ridaforolimus) + MK-0752 Doublets (MKMK) in Patients with Advanced Cancer |
Pamela Munster, MD |
Cancer/Oncology |
|
|
A Phase I Study to Assess the Bioequivalence of 2 Formulations of TKI258, FMI Capsule and FMI Tablet, in Patients with Advanced Solid Tumors |
Pamela Munster, MD |
Cancer/Oncology |
|
|
Communicating about Clinical Trials: Bringing the Cancer Information Service (CIS) to the Underserved [I] |
Nancy Burke, PhD |
Cancer/Oncology |
|
|
Nuevo Amanecer: Promoting the Psychosocial Health of Latinas |
Anna Napoles, PhD, MPH |
Cancer/Oncology, Women's Health |
|
|
Hemoprotein Oxidation and Heme Catabolism |
Paul Ortiz De Montellano, PhD |
Cancer/Oncology |
|
|
Biomarkers for Environmental Exposures in Breast Cancer |
Zena Werb, PhD |
Cancer/Oncology, Women's Health |
|
|
Targeting the translational apparatus in MYCN-driven medulloblastoma |
William Weiss, MD, PhD |
Cancer/Oncology |
|
|
Quality of Mammography Facilities Serving Vulnerable Women |
|
Cancer/Oncology, Women's Health |
|
|
Phase 1b, Open-Label, Dose-Escalation Study of the Safety and Pharmacology of MEGF0444A, A Humanized 1gG1 Antibody in Combination with Bevacizumab with or without Paclitaxel in Patients with Locally Advanced or Metastatic Solid Tumors |
Pamela Munster, MD |
Cancer/Oncology, Pharmacology and Drug Treatment |
|
|
New Approaches to Neuroblastoma Therapy (NANT) |
Katherine Matthay, MD |
Cancer/Oncology, Neurology and Mental Health |
|
|
Prostate Cancer and Pesticides |
Paul Mills, PhD |
Cancer/Oncology, Occupational and Environmental Disease |
|
|
Compassionate Use of Marqibo for the Treatment of Refractory Lymphoblastic Leukemia/Leukemia |
Charalambos (Babis) Andreadis, MD |
Cancer/Oncology, Pharmacology and Drug Treatment |
|
|
New Paradigm of Breast Cancer Causation and Prevention |
Robert Hiatt, MD, PhD |
Cancer/Oncology, Occupational and Environmental Disease |
|
|
Fundamental Mechanobiology of Tumor Progression |
Frank McCormick, PhD, FRS |
Cancer/Oncology |
|
|
New Paradigm of Breast Cancer Causation and Prevention |
Robert Hiatt, MD, PhD |
Cancer/Oncology, Women's Health |
|
|
New Paradigm of Breast Cancer Causation & Prevention |
Robert Hiatt, MD, PhD |
Cancer/Oncology, Women's Health |
|
|
Fundamental Mechanobiology of Tumor Progression |
Frank McCormick, PhD, FRS |
Cancer/Oncology |
|
|
Functional Studies on Genetic Variants of PTPN14 |
Rosemary Akhurst, PhD |
Cancer/Oncology |
|
|
Development of Transporter Targeted Platinum Drugs for Neuroblastoma |
Kathleen Giacomini, PhD |
Cancer/Oncology, Neurology and Mental Health |
|
|
Molecular and Cellular Mechanisms in Cancer |
Zena Werb, PhD |
Cancer/Oncology, Residencies, Fellowships, and Postdoctoral Training |
|
|
Leveraging the California Cancer Registry to Measure and Improve the Quality of Cancer Care |
Robert Hiatt, MD, PhD |
Cancer/Oncology, Health Economics and Effectiveness, Epidemiology and Surveillance |
|
|
Deciphering Cellular Heterogeneity of the Normal Breast to Understand the Origin of Ductal Cancer In Situ (DCIS) |
Laura Esserman, MD |
Cancer/Oncology, Women's Health |
|
|
Study of AMG 479 with Exemestane or Fulvestrant in Postmenopausal Women with Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer |
Michelle Melisko, MD |
Cancer/Oncology, Women's Health |
|
|
Mount Zion Health Fund Transdisciplinary Team Award |
Eric Small, MD |
Cancer/Oncology |
|
|
BEACON Study (BrEAst Cancer Outcomes with NKTR-102): Phase 3 Study of NKTR-102 versus Treatment of Physician's Choice (TPC) in Patients with Locally Recurrent or Metastatic Breast Cancer Previously Treated with Anthracycline, a Taxane and Capecitabine |
Hope Rugo, MD |
Cancer/Oncology, Pharmacology and Drug Treatment, Women's Health |
|
|
A Phase I Open-Label, Dose-Escalation Study of the Phosphoinositide 3-Kinase Inhibitor GSK2126458 in Subjects with Solid Tumors or Lymphoma |
Pamela Munster, MD |
Cancer/Oncology |
|
|
TCGA (Cancer Genome Atlas) |
Michael Prados, MD |
Cancer/Oncology |
|
|
Breast Cancer Risk Reduction: A Patient-Doctor Intervention |
Celia Kaplan, DrPH |
Cancer/Oncology, Women's Health |
|
|
Structuring population health sciences within a faculty of health sciences in East Africa |
Robert Hiatt, MD, PhD |
Cancer/Oncology, Health Systems Strengthening, Training and Capacity Building |
|
|
Environmental and Molecular Epidemiology of Childhood Leukemia |
Mignon Loh, MD |
Cancer/Oncology, Pediatrics |
|
|
AID-Mediated Genetic Instability in Bcr-Abl1-Transformed B Cell Lineage Leukemia |
Markus Muschen, MD, PhD |
Cancer/Oncology |
|
|
Parsing Out The Role Of PI3'-Kinase Signaling In Lung Cancer Initiation, Progression And Therapy |
Martin McMahon, PhD |
Cancer/Oncology |
|
|
Subregional Breast Density and Cancer Risk |
John Shepherd, PhD |
Cancer/Oncology |
|
|
Lipogenic Inhibitors in Prevention of Oncogene Induced Liver Cancer |
Xin Chen, PhD |
Cancer/Oncology |
|
|
Molecular Genetics of Liver Cancers |
Xin Chen, PhD |
Cancer/Oncology, Genetics |
|
|
DAIDS A5298 Study: A Randomized, Double-Blinded, Placebo-Controlled, Phase III Trial of the Quadrivalent HPV Vaccine to Prevent Anal Human Papillomavirus Infection in HIV-Infected Men |
Anne Luetkemeyer, MD |
HIV/AIDS, Cancer/Oncology |
|
|
A Phase 1B, Multi-Center, Open Label, Dose Escalation Study of Oral LDE225 in Combination with BKM120 in Patients with Advanced Solid Tumors |
Pamela Munster, MD |
Cancer/Oncology, Women's Health |
|
|
Regulation of Genomic Instability in Early Breast Cancer |
Thea Tlsty, PhD |
Cancer/Oncology, Immunology |
|
|
HPV Cervical Neoplasia in a Long-Term HIV+ Cohort |
Joel Palefsky, MD |
Sexually Transmitted Infections (STIs), Cancer/Oncology, Women's Health |
|
|
HPV & Cervix Neoplasia in a Large, Long Term HIV+ Cohort |
Teresa Darragh, MD |
Sexually Transmitted Infections (STIs), HIV/AIDS, Cancer/Oncology |
|
|
A Pilot Study of FOLFOX in Combination with Bevacizumab in Patients with Advanced Neuroendocrine Tumors |
Emily Bergsland, MD |
Cancer/Oncology, Pharmacology and Drug Treatment |
|
|
Phase 1 Open-Label First-in-Human Dose-Escalating Safety and Tolerability Study Evaluating Subcutaneous Administration of Andes-1537 for Injection in Patients With Advanced Unresectable Malignancies That Are Refractory to All Standard |
Pamela Munster, MD |
Cancer/Oncology, Pharmacology and Drug Treatment |
|
|
PAAR4Kids-Pharmacogenomics Research Network |
Mignon Loh, MD |
Cancer/Oncology, Genetics, Pharmacology and Drug Treatment |
|
|
CIBMTR Protocol 09-MRD |
Christopher Dvorak, MD |
Cancer/Oncology, Pediatrics |
|
|
Phase 1 Study of IMC-CS4, a Monoclonal Antibody Targeted to the CSF-1 Receptor (CSF-1R), in Subjects With Advanced Solid Tumors Refractory to Standard Therapy or for Which No Standard Therapy is Available |
Hope Rugo, MD |
Cancer/Oncology |
|
|
Creating a Model Integrative Medicine Program for Head and Neck Cancer at the Osher Center |
|
Cancer/Oncology |
|
|
Protocol GS-US-334-0139 An Expanded Access Phase 2 Study of Sofosbuvir and Ribavarin with or without Pegylated Interferon for 24 Weeks in Subjects Who Have Undergone Liver Transplantation and Who Have Aggressive Recurrent Hepatitis C Infection |
Kathleen Tebb, PhD |
Infectious Disease, Cancer/Oncology |
|
|
Mount Zion Health Fund Scholars Program for Recruitment /Retention of Promising Clinical /Translational Investigators |
Eric Small, MD |
Cancer/Oncology, Residencies, Fellowships, and Postdoctoral Training |
|
|
Fusion Genes As Therapeutic Targets in Malignant Pleural Mesothelioma |
Il Jin Kim, PhD |
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Cell Competition in the Developing Mouse Germline |
Diana Laird, PhD |
Cancer/Oncology, Family Planning, Pediatrics, Newborn and Infant Health |
|
|
Oncogenic Viral Biomarkers in Nonmalignant Human Breast Tissue |
Kimberly Baltzell, RN, PhD, MS |
Cancer/Oncology, Drug and Diagnostics Development, Women's Health |
|
|
A Phase Ib Dose Escalation/Randomized Phase II, Multicenter, Open-label Study of BYL719 in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma |
Pamela Munster, MD |
Cancer/Oncology |
|
|
Risk of Leukemia after Protracted Exposures to Low Doses of Ionizing Radiation. |
Lydia Zablotska, MD, MPA, PhD |
Noncommunicable and/or Chronic Disease, Cancer/Oncology, Genetics, Epidemiology and Surveillance, Risk Reduction and Prevention |
|
|
Using Epigenetic Changes to Stratify DCIS Biopsies |
Thea Tlsty, PhD |
Cancer/Oncology, Women's Health |
|
|
Lay health workers and colorectal cancer screening among Chinese Americans |
Tung Nguyen, MD |
Cancer/Oncology, Patient and Peer Education |
|
|
Explosive Evolution Under Stress: the Driving Forces of Cancer Dynamics - Project 2 |
Thea Tlsty, PhD |
Cancer/Oncology |
|
|
Center for Interdisciplinary Research on Childhood Leukemia and the Environment |
John Balmes, MD |
Cancer/Oncology, Occupational and Environmental Disease, Pediatrics |
|
|
Explosive Evolution Under Stress: the Driving Forces of Cancer Dynamics - Project 1 |
Thea Tlsty, PhD |
Cancer/Oncology |
|
|
Predicting Early and Late Recurrence to Improve Care |
Laura Esserman, MD |
Cancer/Oncology, Women's Health |
|
|
Environmental effects of the mammary gland across the lifespan |
Zena Werb, PhD |
Cancer/Oncology, Occupational and Environmental Disease, Women's Health |
|
|
Using Epigenetic Changes to Stratify DCIS Biopsies |
Thea Tlsty, PhD |
Cancer/Oncology, Women's Health |
|
|
Environmental and Molecular Epidemiology of Childhood Leukemia |
Joseph Wiemels, PhD |
Cancer/Oncology |
|
|
Training Program in Translational Brain Tumor Research |
Russell Pieper, PhD |
Cancer/Oncology, Residencies, Fellowships, and Postdoctoral Training |
|
|
Spirit of Eagles Communities Network Program |
Neal Benowitz, MD |
Cancer/Oncology |
|
|
Non-Invasive Assessment of Bone Micro-Architecture and Strength Changes in Androgen Deprivation Therapy in Prostate Cancer As a Model for Male Secondary Osteoporosis |
Sharmila Majumdar, PhD |
Cancer/Oncology |
|
|
Role of Fibroblasts, Myeloid Cells and Matrix in Pancreatic Ductal Adenocarcinoma (PDAC) |
Valerie Weaver, PhD |
Cancer/Oncology |
|
|
Uganda-UCSF Research Training Program in HIV-Associated Malignancies |
Jeffrey Martin, MD, MPH |
HIV/AIDS, Cancer/Oncology |
|
|
MiRNAs as prognostic markers for prostate cancer patients on active surveillance |
Robert Blelloch, MD, PhD |
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Redes En Acción: National Latino Cancer Research Network |
Eliseo Perez-Stable, MD |
Cancer/Oncology |
|
|
Regulation of Mammary Epithelial Signaling by Local Matrix Stiffness |
Thea Tlsty, PhD |
Cancer/Oncology, Women's Health |
|
|
AIDS Malignancies Consortium |
Lawrence Kaplan, MD |
HIV/AIDS, Cancer/Oncology |
|
|
HPV-Related Neoplasia among HIV-Seropositive Indian Men Who Have Sex With Men |
Joel Palefsky, MD |
HIV/AIDS, Cancer/Oncology |
|
|
A comparison of the preferences among HIV+ and low risk women towards Cervical Cancer Screening and Prevention using health utilities: A Quantitative Study |
Keerthana Anand, MS |
HIV/AIDS, Cancer/Oncology, Women's Health |
|
|
Human papillomavirus and the impact of needle-free vaccination on incidence in Thai women: a quantitative study |
Sneh Patel, MS |
Infectious Disease, Cancer/Oncology, Pediatrics |
|
|
Imaging Oncogene Activation and Tumor Development in Genetically Engineered Mice |
Martin McMahon, PhD |
Cancer/Oncology |
|
|
Prenatal Exposures, DNA Methylation & Childhood Leukemia |
Joseph Wiemels, PhD |
Cancer/Oncology, Pediatrics |
|
|
A Study of Etiology of Esophageal Cancer in Tanzania (SEEC-Tanzania) |
Peter Carroll, MD |
Cancer/Oncology |
|
|
Radiation Oncology Solutions in Tanzania |
Owen Kenton, MS |
Cancer/Oncology |
|
|
Immune and Collagen Basis of Breast Cancer |
Valerie Weaver, PhD |
Cancer/Oncology, Women's Health |
|
|
Embryonic signaling pathways in pancreatic cancer |
Matthias Hebrok, PhD |
Cancer/Oncology |
|
|
HIV, Gut Epithelial Cell Turnover and Mucosal Inflammation, and the Risk of Colorectal Neoplasia |
Ma Somsouk, MD, MAS |
HIV/AIDS, Cancer/Oncology |
|
|
The GNAQ pathway as a therapeutic target in uveal melanoma |
Boris Bastian, MD, PhD |
Cancer/Oncology |
|
|
GINI: Gardasil Immunogenicity with Needle-free Injection-Safety and Immunogenicity of Gardasil using IM and ID needle-free injection delivery |
Joel Palefsky, MD |
Sexually Transmitted Infections (STIs), Cancer/Oncology |
|
|
Phase IA, Multicenter, Open-label Dose Escalation Study of Oral BYL719, in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene |
Hope Rugo, MD |
Cancer/Oncology |
|
|
Partnership to Advance Breast Cancer Research |
Tracey Woodruff, PhD, MPH |
Cancer/Oncology, Women's Health |
|
|
Clinical Investigator Research Program for Pilot Research Studies 2014 |
Eric Small, MD |
Cancer/Oncology, Residencies, Fellowships, and Postdoctoral Training |
|
|
Support for a Multiple Myeloma Project Coordinator |
Jeffrey Wolf, MD |
Cancer/Oncology |
|
|
International Case-Control Study of Malignant Glioma |
Margaret Wrensch, PhD |
Cancer/Oncology |
|
|
JBAL: A Phase 2 Study of LY2157299 Monohydrate Monotherapy or LY2157299 Monohydrate plus Lomustine Therapy compared to Lomustine Monotherapy in Patients with Recurrent Glioblastoma |
Nicholas Butowski, MD |
Cancer/Oncology, Pharmacology and Drug Treatment |
|
|
Targeting Adaptive Pathways in Resistant CRPC |
Eric Small, MD |
Cancer/Oncology |
|
|
Phase I Study of INC280 plus Erlotinib in Patients With C-Met Expressing Non-Small Cell Lung Cancer. |
|
Cancer/Oncology |
|
|
Risk-Benefit Trade-Offs for Whole Genome Sequencing |
Kathryn Phillips, PhD |
Cancer/Oncology, Genetics |
|
|
Thai Red Cross S&S, HN177 |
Joel Palefsky, MD |
Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology |
|
|
A Multicenter Phase I/II Trial of Abiraterone + BEZ235 in Metastatic, Castration-Resistant Prostate Cancer |
Charles Ryan, MD |
Cancer/Oncology |
|
|
Lung Cancer Screening: The Views of Patients and Physicians |
Celia Kaplan, DrPH |
Cancer/Oncology, Chronic Respiratory Disease |
|
|
A phase I/II, multicenter, open-label dose finding study of oral CFG920 in patients with metastatic castration-resistant prostate cancer |
Charles Ryan, MD |
Cancer/Oncology |
|
|
Pathogenesis of HIV-Related Bacillary Angiomatosis |
Jane Koehler, MD |
Infectious Disease, HIV/AIDS, Opportunistic Infection, Cancer/Oncology |
|
|
Meeting the self-care needs of Latinas after Breast Cancer |
Anna Napoles, PhD, MPH |
Cancer/Oncology, Women's Health, Access or Barriers to Care, Immigration and Migration |
|
|
TGF-ß Suppression and Promotion of Mammary Carcinomas |
Valerie Weaver, PhD |
Cancer/Oncology, Women's Health |
|
|
UCSF Cutaneous Immunology Core: OSM Project |
|
Opportunistic Infection, Cancer/Oncology, Immunology |
|
|
Cellular and Genetic Basis of Anaplastic Medulloblastoma |
William Weiss, MD, PhD |
Cancer/Oncology, Pediatrics |
|
|
A Phase I Study of Convection-Enhanced, Image-Assisted Delivery of Liposomal-Irinotecan Using Imaging in High Grade Glioma |
Nicholas Butowski, MD |
Cancer/Oncology |
|
|
Infectious Origins of Childhood Leukemia [II] |
Markus Muschen, MD, PhD |
Cancer/Oncology |
|
|
Enabling New Translational Discoveries Using a Genomic Data-Driven Nosology |
Atul Butte, MD, PhD |
Cancer/Oncology, Immunology |
|
|
Extracellular Proteolysis as a Molecular Stratification Tool for Cancer |
Charles Craik, PhD |
Cancer/Oncology |
|
|
Project 2: Human Melanoma -- Etiology, Progression, and Therapy |
Boris Bastian, MD, PhD |
Cancer/Oncology |
|
|
Impact of molecular phenotype on glioma metabolism and growth |
Sarah Nelson, PhD |
Cancer/Oncology |
|
|
Patient Centered Videos to Enhance Informed Consent for Palliative Chemotherapy |
Katherine Van Loon Steitz, MD, MPH |
Cancer/Oncology |
|
|
Translating a Stress Management Program for Latinas |
Anna Napoles, PhD, MPH |
Cancer/Oncology, Women's Health, Access or Barriers to Care |
|
|
Beacon (Breast Cancer Outcomes with Nktr-102): a Phase 3 Study of Nktr-102 Versus Treatment of Physician's Choice in Patients with Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline, Taxane and Capecitabine |
Hope Rugo, MD |
Cancer/Oncology, Women's Health |
|
|
A Phase II, Single Arm Study of the Use of Steroid-Based Mouthwash to Prevent Stomatitis in Postmenopausal Women with Advanced or Metastatic Hormone Receptor Positive Breast Cancer Being Treated with Everolimus plus Exemestane. |
Hope Rugo, MD |
Cancer/Oncology, Women's Health |
|
|
International Collaborative of prospective studies of HIV and Hepatitis in IDU |
Stephen Shiboski, PhD |
Sexually Transmitted Infections (STIs), Cancer/Oncology |
|
|
Risk-Based Screening: An Initiative to Dramatically Improve Our Approach to Screening and Prevention |
Laura Esserman, MD |
Cancer/Oncology |
|
|
Breast Cancer and the Environment Research Program Coordinating Center |
Robert Hiatt, MD, PhD |
Cancer/Oncology |
|
|
Exploring the Role of CDK4 and CDK6 in Melanoma Maintenance |
Martin McMahon, PhD |
Cancer/Oncology |
|
|
Cellular mechanisms of resistance to chemotherapy and the impact of immune modulating therapy, and molecular characterization of circulating tumor cells (CTCs) in patients with advanced breast cancer (ABC) |
Hope Rugo, MD |
Cancer/Oncology, Women's Health |
|
|
Kaiser Permanente Cervical Cancer Prevention (CCaP) Network |
George Sawaya, MD |
Cancer/Oncology, Women's Health |
|
|
Symptoms Clusters in Oncology Patients Receiving Chemotherapy |
Christine Miaskowski, RN, PhD, FAAN |
Cancer/Oncology |
|
|
A Phase II Trial of HKI-272 (Neratinib) for Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer and Brain Metastases (TBCRC 022) |
Michelle Melisko, MD |
Cancer/Oncology, Neurology and Mental Health, Women's Health |
|
|
TBCRC 22: A Phase II Trial of HKI-272 (Neratinib) for Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast cancer and Brain Metastases |
Michelle Melisko, MD |
Cancer/Oncology, Neurology and Mental Health, Women's Health |
|
|
Master Member Agreement: Translational Breast Cancer Research Consortium |
Hope Rugo, MD |
Cancer/Oncology, Epidemiology and Surveillance |
|
|
Maintain a Health Professional Career Opportunity Program |
Renee Navarro, MD |
Cancer/Oncology |
|
|
Accurate, long-read sequencing with droplet-microfluidic barcoding |
Adam Abate, PhD |
Infectious Disease, Cancer/Oncology, Genetics |
|
|
The Breast Cancer Clinical Trials Consortium |
Hope Rugo, MD |
Cancer/Oncology, Women's Health |
|
|
SPORE in Head and Neck Cancer - Project 2 |
|
Cancer/Oncology |
|
|
Postdoctoral training in tobacco control |
Stanton Glantz, PhD |
Cancer/Oncology, Smoking and Tobacco, Residencies, Fellowships, and Postdoctoral Training |
|
|
The Meningioma Consortium: Genome-Wide Association Study |
Joseph Wiemels, PhD |
Cancer/Oncology |
|
|
Promoting Post-Treatment Self-Management among Latinos with Cancer |
Anna Napoles, PhD, MPH |
Cancer/Oncology, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination |
|
|
Decision-Making about CAM Across the Cancer Continuum: An Observational Study |
Barbara Koenig, PhD |
Cancer/Oncology |
|
|
Medical Scientist Training Program |
Mark Anderson, MD, PhD |
Noncommunicable and/or Chronic Disease, Cancer/Oncology, Dementia and Cognitive Impairment, Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education |
|
|
Non-Invasive Differentiation of Benign Lesions from Aggressive Pancreatic Cancer |
Charles Craik, PhD |
Cancer/Oncology |
|
|
Effect of an embedded palliative care program on the unmet needs of patients with metastatic breast cancer. |
Melanie Majure, MD |
Cancer/Oncology, Women's Health |
|
|
MR Metabolic Imaging of Response to Targeted Therapies in GBM |
Sabrina Ronen, PhD |
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Fatty acid transporters in cholangiocarcinoma pathogenesis |
Xin Chen, PhD |
Cancer/Oncology |
|
|
Antiretroviral Therapy Strategies to Lower Cancer Risk in HIV-Infected Persons |
Nancy Hessol, MSPH |
HIV/AIDS, Cancer/Oncology |
|
|
Negative Feedback and oncogene signaling in leukemia |
Markus Muschen, MD, PhD |
Cancer/Oncology |
|
|
Personal Patient Profile - Prostate (P3P): A Randomized Multi-site Trial |
Leslie Wilson, PhD, MS |
Cancer/Oncology |
|
|
131I-MIBG Imaging and Therapy for Neuroblastoma: Infrastructure Proposal |
Katherine Matthay, MD |
Cancer/Oncology |
|
|
Interplay between tension and inflammation in pancreatic tumor progression |
Valerie Weaver, PhD |
Cancer/Oncology |
|
|
Exploring the Role of CDK4 and CDK6 in Melanoma Maintenance |
Martin McMahon, PhD |
Cancer/Oncology |
|
|
Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia |
Markus Muschen, MD, PhD |
Cancer/Oncology, Pediatrics |
|
|
Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer - Core A |
|
Cancer/Oncology |
|
|
Effects of Maraviroc on HIV-related Kaposi Sarcoma |
Toby Maurer, MD |
HIV/AIDS, Cancer/Oncology |
|
|
The Effectiveness of Screening HIV-Infected Women for Anal Cancer Precursors |
Teresa Darragh, MD |
HIV/AIDS, Cancer/Oncology, Women's Health |
|
|
Lung Cancer Screening: Development of a Clinic-Based Intervention |
Celia Kaplan, DrPH |
Cancer/Oncology |
|
|
Leukocyte Biomarkers for Predicting Human Breast Cancer Outcomes |
Matthew Krummel, PhD |
Cancer/Oncology |
|
|
Elucidating the Fundamental Biology of Memory Regulatory T cells in Skin |
|
Cancer/Oncology, Immunology |
|
|
Predicting Early and Late Recurrence to Improve Care |
Laura Esserman, MD |
Cancer/Oncology, Women's Health |
|
|
The Effectiveness of Screening HIV-Infected Women for Anal Cancer Precursors |
Teresa Darragh, MD |
HIV/AIDS, Cancer/Oncology, Women's Health |
|
|
Epigenetic Markers of Age and Diurnal Levels of Fatigue during Chemotherapy |
Kathryn Lee, RN, PhD, FAAN |
Cancer/Oncology, Women's Health |
|
|
Clinical Investigator Research Program for Pilot Research Studies 2013 |
Eric Small, MD |
Cancer/Oncology |
|
|
Targeting the c-Met/HGF Axis in acute Myeloid Leukemia |
Charalambos (Babis) Andreadis, MD |
Cancer/Oncology |
|
|
Administrative Supplements to Cancer Centers Support Grants to Stimulate Collaborative HIV Malignancy Research in Low and Middle Income Countries |
Joel Palefsky, MD |
HIV/AIDS, Cancer/Oncology, Women's Health |
|
|
The role of HDAC2 in hormone therapy resistance |
Pamela Munster, MD |
Cancer/Oncology |
|
|
Breast Cancer Surveillance Consortium Data Resource |
Karla Kerlikowske, MD |
Cancer/Oncology, Women's Health |
|
|
Enhancing the Efficacy of Chemotherapy in Triple Negative/Basal-like Breast Cancer by Targeting Macrophages |
Hope Rugo, MD |
Cancer/Oncology |
|
|
Tissue Biopsy Samples from Head and Neck Cancers |
Charles Chiu, MD, PhD |
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Genetics of Mammographic Density in Ashkenazi Jews |
Elad Ziv, MD |
Cancer/Oncology, Genetics |
|
|
Comparative Effectiveness of Antiretroviral Therapy (ART) with Upfront Chemotherapy versus ART Alone in HIV-Infected Patients with Kaposi Sarcoma without Urgent Indications for Chemotherapy |
Jackie (Chia-Ching) Wang, MD |
HIV/AIDS, Opportunistic Infection, Cancer/Oncology, Pharmacology and Drug Treatment |
|
|
Genome wide association study of breast cancer subtype and survival in Latinas |
Laura Fejerman, PhD |
Cancer/Oncology, Genetics, Epidemiology and Surveillance |
|
|
Characterization of and Treatment for Chemotherapy Neuropathy |
Christine Miaskowski, RN, PhD, FAAN |
Cancer/Oncology, Neurology and Mental Health |
|
|
Regulation and Targets of the DNA Damage Checkpoint |
David Toczyski, PhD |
Cancer/Oncology |
|
|
Modeling Juvenile Myelomonocytic Leukemia with Patient-Derived Induced Pluripotent Stem Cells |
Mignon Loh, MD |
Cancer/Oncology, Adolescent Health |
|
|
Risk of hematologic cancers from repeated low-dose diagnostic radiation. |
Lydia Zablotska, MD, MPA, PhD |
Cancer/Oncology, Occupational and Environmental Disease |
|
|
Risk-Based Breast Cancer Screening in Community Settings |
Karla Kerlikowske, MD |
Cancer/Oncology, Women's Health |
|
|
Microtubule Complexes Involved in Intracellular Transport |
Ronald Vale, PhD |
Cancer/Oncology |
|
|
PRESENT: Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax Treatment |
Michelle Melisko, MD |
Cancer/Oncology, Women's Health |
|
|
Pancreatic Cancer Research Pilot Project |
Margaret Tempero, MD |
Cancer/Oncology |
|
|
Pharmacological hyperactivation of Ras-MAPK signaling to target Ph+ ALL |
Markus Muschen, MD, PhD |
Cancer/Oncology, Pediatrics |
|
|
HPV testing of samples from the AIDS Malignancy Consortium |
Joel Palefsky, MD |
HIV/AIDS, Opportunistic Infection, Cancer/Oncology |
|
|
Evaluation of Pomalidomide in Combination with High Dose Dexamethasone and Oral Cyclophosphamide in Patients with Relapsed and Refractory Myeloma |
Thomas Martin, MD |
Cancer/Oncology, Pharmacology and Drug Treatment |
|
|
Evaluation of Pao Pereira, a natural product of the extract of rainforest tree, in malignant brain tumor cell lines |
Nicholas Butowski, MD |
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Deep Sequencing Recessive Dystrophic Epidermolysis Bullosa Squamous Cell Carcinoma |
Raymond Cho, MD, PhD |
Cancer/Oncology |
|
|
Phase II study of letrozole with or without BYL719 or buparlisib, for the neoadjuvant treatment of postmenopausal women with hormone receptor-positive HER2-negative breast cancer |
Hope Rugo, MD |
Cancer/Oncology |
|
|
Influence of germ line genetic variation on myeloma progression and survival |
Elad Ziv, MD |
Cancer/Oncology |
|
|
PRE-VIEW An Interactive Video Doctor to Encourage Cancer Screening |
Judith Walsh-Cassidy, MD, MPH |
Cancer/Oncology, Access or Barriers to Care, Patient and Peer Education |
|
|
A Causal Role for Asymmetric Cell Division Defects in Glioma Initiation |
Claudia Petritsch, PhD |
Noncommunicable and/or Chronic Disease, Cancer/Oncology |
|
|
Prostate Cancer Therapeutic Clinical Investigation "First in Man" |
Eric Small, MD |
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Mechanisms and Therapeutics for Glucocorticoid-Resistant Leukemia |
Keith Yamamoto, PhD |
Cancer/Oncology |
|
|
Identifying neurofibromin-specific regulatory nodes for therapeutic targeting in NF1 |
Frank McCormick, PhD, FRS |
Cancer/Oncology |
|
|
Dar es Salaam ESCC Case-Control Study |
Katherine Van Loon Steitz, MD, MPH |
Cancer/Oncology |
|
|
Cutting Edge Lineage Tracking of Tumor-Educated Immune Cells |
Matthew Krummel, PhD |
Cancer/Oncology |
|
|
Breast Cancer Screening and Outcomes in Diverse Populations: Role of Comorbidity |
|
Cancer/Oncology, Women's Health |
|
|
CAPTC - Institute for Human Virology - Nigeria (IHVN) Partner Testing Services |
Michael Policar, MD, MPH |
Cancer/Oncology |
|
|
Study of the histone deacetylase inhibitor Panobinostat (LBH589) in combination with standard dose Cytarabine and Daunorubicin for older patients with untreated acute Mmyeloid leukemia or advanced myelodysplasia |
Charalambos (Babis) Andreadis, MD |
Cancer/Oncology |
|
|
Molecular genetic, host-derived and clinical determinants of long-term survival in glioblastoma |
Jennifer Clarke, MD, MPH |
Cancer/Oncology, Genetics |
|
|
Three Center Symposium |
|
Cancer/Oncology |
|
|
Rational Combined Inhibition of NF-kB and EGFR to Optimize Lung Cancer Treatment |
Trever Bivona, MD, PhD |
Cancer/Oncology, Chronic Respiratory Disease |
|
|
Identification of the SNPs and their Interaction with environmental factors in Esophageal Cancer in Tanzania |
Li Zhang, PhD |
Cancer/Oncology, Occupational and Environmental Disease |
|
|
Using Comparative Effectiveness Analyses to Optimize Cervical Cancer Screening |
George Sawaya, MD |
Cancer/Oncology |
|
|
Tumor Recurrence and Drug Resistance in Non-Small Cell Lung Cancer Through Modulation of the Cytoskeleton and Activation of YAP |
|
Cancer/Oncology |
|
|
A Randomized Phase 2 Study of Cabozantinib (XL184) in Combination with Abiraterone in Chemotherapy Naïve Subjects with Bone-Metastatic Castration-Resistant Prostate Cancer |
Charles Ryan, MD |
Cancer/Oncology |
|
|
An Open-Label, Multicenter Extension Study of Trastuzumab-MCC-DM1 in Patients Previously Treated with T-DM1 in a Genentech-Sponsored T-DM1 Study |
Hope Rugo, MD |
Cancer/Oncology, Women's Health |
|
|
A Phase Ib/II, Multicenter Study of the Combination of LEE011 and BYL719 with Letrozole in Adult Patients with Advanced ER+ Breast Cancer |
Pamela Munster, MD |
Cancer/Oncology, Women's Health |
|
|
Genetic network analysis of cancer targets |
William Weiss, MD, PhD |
Cancer/Oncology |
|
|
Serum Androgens as Predictors of Survival in Metastatic Prostate Cancer |
Charles Ryan, MD |
Cancer/Oncology |
|
|
Advanced Methods to Evaluate Extracellular Matrix and Crosslinking in the Tumor Microenvironment |
Valerie Weaver, PhD |
Cancer/Oncology |
|
|
Engaging Underserved Women in Health Research |
Galen Joseph, PhD |
Cancer/Oncology, Women's Health |
|
|
A Phase 2 Pilot Feasibility Study of Palbociclib in Combination with Adjuvant Endocrine Therapy for Hormone Receptor Positive Invasive Breast Carcinoma. |
Hope Rugo, MD |
Cancer/Oncology, Women's Health |
|
|
New Instrumentation and Techniques for Hyperpolarized Metabolic and Perfusion MRI |
Daniel Vigneron, PhD |
Cancer/Oncology |
|
|
CC#14952: Phase IB Study of MK-3475 in Subjects with Select Advanced Solid Tumors |
Hope Rugo, MD |
Cancer/Oncology, Pharmacology and Drug Treatment |
|
|
(PQC4) Fate of cells disseminating from human breast cancer xenografts |
Zena Werb, PhD |
Cancer/Oncology, Risk Reduction and Prevention |
|
|
The PROMOTE Program: Precision Oncology and Molecular Targeting in Advanced Prostate Cancer Advancing the Promise of the PCF/SU2C/AACR West Coast Prostate Cancer Dream Team |
Eric Small, MD |
Cancer/Oncology |
|
|
Randomized Trial to Increase Adherence to Cervical Cancer Screening Guidelines for Young Women |
Anna-Barbara Moscicki, MD |
Cancer/Oncology, Women's Health |
|
|
University of California Global Health Institute Program for Fellows and Scholars |
Craig Cohen, MD, MPH |
Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Effectiveness, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, Policy and Standards of Care, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training |
|
|
Murine Neuroblastoma Models for Preclinical Therapeutics |
William Weiss, MD, PhD |
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Natural History of HPV in Teens-Infection to Neoplasia |
Stephen Shiboski, PhD |
Sexually Transmitted Infections (STIs), Cancer/Oncology, Adolescent Health |
|
|
East Africa IEDEA Regional Consortium |
Craig Cohen, MD, MPH |
HIV/AIDS, Tuberculosis, Cancer/Oncology, Epidemiology and Surveillance |
|
|
Clinical Investigator Research Program for Pilot Research |
Eric Small, MD |
Cancer/Oncology |
|
|
Genetic and Epidemiological Approaches to Breast Density and Breast Cancer Risk |
Elad Ziv, MD |
Cancer/Oncology, Women's Health |
|
|
Genetic Susceptibility to Pediatric Glioma in Individuals and Diverse populations |
Joseph Wiemels, PhD |
Cancer/Oncology, Pediatrics |
|
|
CARAVAN: Checkpoint-Radiation-Vaccine Neoadjuvant Trial for Metastatic Prostate Cancer |
Lawrence Fong, MD |
Cancer/Oncology |
|
|
Evaluation of technetium Tc 99m tilmanocept (Lymphoseek) Localization, Retention, and Distribution in Primary Cutaneous Kaposi's Sarcoma (KS) and Lymphatic Drainage from KS Lesions by SPECT and SPECT/CT Imaging |
Toby Maurer, MD |
HIV/AIDS, Cancer/Oncology, Pharmacology and Drug Treatment |
|
|
Translating Cancer Genetics for the Safety Net Setting |
Galen Joseph, PhD |
Cancer/Oncology, Genetics, Women's Health |
|
|
Real-World Treatment Patterns and Associated Outcomes Among Patients with Advanced Progressive Pancreatic Neuroendocrine Tumors |
Emily Bergsland, MD |
Cancer/Oncology |
|
|
BRAF Mutation in Malignant Astrocytoma Origin, Evolution, and Response to Therapy |
Claudia Petritsch, PhD |
Cancer/Oncology |
|
|
Comparative Effectiveness of Breast Cancer Screening, Diagnosis, and Management in Community Practice |
Karla Kerlikowske, MD |
Cancer/Oncology, Women's Health |
|
|
The Role of PD-1 Pathway and Tissue Microenvironment in HIV-Kaposi Sarcoma and Endemic Kaposi Sarcoma Cohort in Western Kenya |
Toby Maurer, MD |
HIV/AIDS, Cancer/Oncology |
|
|
Probing Tumor Metastasis through Chemical Cell Surface Engineering |
Valerie Weaver, PhD |
Cancer/Oncology, Immunology |
|
|
UCSF-GIVI Center for AIDS Research (CFAR) |
Paul Volberding, MD |
HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Drug and Diagnostics Development, Immunology, Pharmacology and Drug Treatment, Neurology and Mental Health, Trauma and PTSD, Women's Health, Pediatrics, Implementation and Behavioral Science, Training and Capacity Building, Training International Scholars and Clinicians |
|
|
Enabling a Paradigm Shift: A Preference-Tolerant RCT of Personalized vs. Annual Screening for Breast Cancer |
Laura Esserman, MD |
Cancer/Oncology, Women's Health |
|
|
Molecular Genetics of Liver Cancers |
Xin Chen, PhD |
Cancer/Oncology, Genetics |
|
|
Treatment Decision Making Involvement in Adolescents and Young Adults With Cancer |
Kimberly A. Pyke-Grimm, RN, MN, CNS |
Cancer/Oncology, Adolescent Health |
|
|
Obesity, Body Fat Distribution and Cancer Risk in the Multiethnic Cohort (Core C) |
John Shepherd, PhD |
Cancer/Oncology, Diet, Exercise, and Obesity |
|
|
The Breast Cancer Clinical Trials Consortium |
Hope Rugo, MD |
Cancer/Oncology, Women's Health |
|
|
Translational development of a novel antibody-drug conjugates against myeloma |
Bin Liu, PhD |
Cancer/Oncology, Immunology |
|
|
Improving outcomes for JMML (juvenile myelomonocytic leukaemia) through targeted therapeutics |
Mignon Loh, MD |
Cancer/Oncology, Pediatrics |
|
|
Monitoring Physical Activity During Chemotherapy Among Breast Cancer Patients: A Needs Assessment to Develop Interventions to Help Prevent Functional Decline |
Laura Esserman, MD |
Cancer/Oncology, Women's Health |
|
|
A Phase III, Open-Label, Randomized Study of MPDL3280A (Anti-PD-L1 Antibody) in Combination with Bevacizumab versus Sunitinib in Patients with Untreated Advanced Renal Cell Carcinoma |
Lawrence Fong, MD |
Cancer/Oncology |
|
|
Molecular Mechanisms Underlying Tumor Progression Despite Enzalutamide Treatment |
Eric Small, MD |
Cancer/Oncology, Pharmacology and Drug Treatment |
|
|
Phase III Study Evaluating Palbociclib (PD-0332991), a Cycline-Dependent Kinase (CDK) 4/6 Inhibitor in Patients with Hormone-Receptor-Positive, HER2-Normal Primary Breast Cancer with High Relapse Risk after Neoadjuvant Chemotherapy "Penelope" |
Hope Rugo, MD |
Cancer/Oncology, Women's Health |
|
|
Targeting MYC-Driven Cell Cycle Progression in Neuroendocrine Prostate Cancer with Gallium Citrate PET as a Novel Biomarker of MYC Transcriptional Activity |
Rahul Aggarwal, MD |
Cancer/Oncology, Drug and Diagnostics Development |
|
|
Hedgehog signaling and signal transduction |
Thomas Kornberg, PhD |
Cancer/Oncology |
|
|
Modular phase II study to link targeted therapy to patients with pathway activated tumors: Module 6 - BGJ398 for patients with tumors with FGFR genetic alterations |
Jackie (Chia-Ching) Wang, MD |
Cancer/Oncology |
|
|
New ways of treating pancreatic cancer based on reversing K-Ras-mediated stemness |
Frank McCormick, PhD, FRS |
Cancer/Oncology, Immunology |
|
|
New Paradigm of Breat Cancer Causation and Prevention - Phase II |
Robert Hiatt, MD, PhD |
Cancer/Oncology, Occupational and Environmental Disease, Women's Health |
|
|
Metabolic Reprogramming in Brain Tumors |
Sabrina Ronen, PhD |
Cancer/Oncology |
|
|
A Phase II, Open Study of the Clinical Activity, Safety and Tolerability of Lapatinib in Combination with Bevacizumab in Subjects with Advanced or Metastatic ErbB-2-Overexpressing Breast Cancer |
Hope Rugo, MD |
Cancer/Oncology, Women's Health |
|
|
Identifying Human Breast Carcinogens Using Exposomics (2) |
Laura Fejerman, PhD |
Cancer/Oncology, Women's Health |
|
|
Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis |
John Shepherd, PhD |
Noncommunicable and/or Chronic Disease, Cancer/Oncology, Risk Reduction and Prevention |
|
|
Study of Paclitaxel eith GDC-0941 vs Paclicaxel with placebo in patients with locally recurrent or Metastatic Breast Cancer |
Michelle Melisko, MD |
Cancer/Oncology, Women's Health |
|
|
Targeting Oncogenic BRAF And PI3'-Kinase Signaling For Melanoma Therapy |
Martin McMahon, PhD |
Cancer/Oncology |
|
|
Molecular Methods for Cervical Cancer Screening in HIV+ Women |
Nancy Hessol, MSPH |
Cancer/Oncology, Drug and Diagnostics Development, Women's Health |
|
|
The Prostate Cancer Clinical Trials Consortium: Clinical Research Site Application |
Charles Ryan, MD |
Cancer/Oncology |
|
|
Phase II Study of MK-3475 with and without Bevacizumab for Recurrent Glioblastoma |
Jennifer Clarke, MD, MPH |
Cancer/Oncology, Pharmacology and Drug Treatment |
|
|
Negative feedback signaling in tyrosine kinase-driven leukemia |
Markus Muschen, MD, PhD |
Cancer/Oncology |
|
|
Targeting BCL6 in tyrosine kinase-driven leukemia |
Markus Muschen, MD, PhD |
Cancer/Oncology |
|
|
Three Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) |
Alan Venook, MD |
Cancer/Oncology, Drug and Diagnostics Development, Pharmacology and Drug Treatment |
|
|
PNOC-002: Safety, Phase 0, and Pilot Efficacy Study of vemurafenib, an oral inhibitor of BRAFV600E, in Children with Recurrent/Refractory BRAFV600E-mutant gliomas |
Michael Prados, MD |
Cancer/Oncology, Pharmacology and Drug Treatment, Pediatrics |
|
|
(PQ5) Role of HIV-associated cellular miRNAs in HPV 16-induced pathogenesis |
Joel Palefsky, MD |
Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology |
|
|
Randomized Trial to Increase Adherence to Cervical Cancer Screening Guidelines for Young Women (UCSF sub-in) |
Heike De Bocanegra, MPH, PhD |
Cancer/Oncology, Women's Health |
|
|
Randomized Controlled Trial of the Effect of the Livongo Health Diabetes Management Program vs. Standard Care on Glycemic Control |
Jeffrey Olgin, MD |
Cancer/Oncology |
|
|
Head and Neck Cancer as a Model for Bedside-to-Bench Research |
|
Cancer/Oncology |
|
|
Physical and Genetic Interaction Landscape of the Tyrosine Kinome |
Nevan Krogan, PhD, MSc |
Cancer/Oncology, Diabetes, Immunology |
|
|
Management of esophageal cancer in East Africa: a prospective cohort study of treatment strategies and supportive care |
Geoffrey Buckle, MD, MPH |
Noncommunicable and/or Chronic Disease, Cancer/Oncology |
|
|
Metastatic escape mechanisms in TKI resistant lung cancer |
|
Cancer/Oncology |
|
|
Cardiovascular, Pulmonary & Hematological Disease in HIV: Prevention & Treatment |
Peter Hunt, MD |
HIV/AIDS, Cancer/Oncology, Cardiovascular Disease, Aging |
|
|
Exome sequencing in Diverse Populations in Colorado & Oregon |
Galen Joseph, PhD |
Cancer/Oncology, Drug and Diagnostics Development, Access or Barriers to Care |
|
|
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Study of ARN-509 in Men with Non-Metastatic (M0) Castration-Resistant Prostate Cancer |
Eric Small, MD |
Cancer/Oncology |
|
|
Early Stage Diagnosis of Kaposi's Sarcoma in Limited Resource Settings using KS-Detect |
Jeffrey Martin, MD, MPH |
HIV/AIDS, Cancer/Oncology, Drug and Diagnostics Development |
|
|
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods |
Daniel Vigneron, PhD |
Cancer/Oncology |
|
|
A Phase I/II Study Evaluating Microwave Hyperthermia and Thermodox (Lyso-Thermosensitive Liposomal Doxorubicin) in Patients with Breast Cancer Recurrence at the Chest Wall (DIGNITY) |
Hope Rugo, MD |
Cancer/Oncology, Women's Health |
|
|
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods |
Daniel Vigneron, PhD |
Cancer/Oncology |
|
|
Perinatal Immune Development and Risk of Childhood Acute Lymphoblastic Leukemia |
Joseph Wiemels, PhD |
Cancer/Oncology, Pediatrics |
|
|
DLM-10-001: An Open-Label, Single Arm, Safety and Tolerability Dose-escalation Study of DAG in Patients with Recurrent Malignant Glioma or Progressive Secondary Brain Tumor |
Nicholas Butowski, MD |
Cancer/Oncology |
|
|
Caring in and Beyond the Clinic; Development of a Community-based Care Navigation Program for Radiation Oncology |
Galen Joseph, PhD |
Cancer/Oncology, Patient and Peer Education |
|
|
HIV/HPV cancer prevention treatment and pathogenesis: Rwanda /Einstein Consortium |
Joel Palefsky, MD |
HIV/AIDS, Opportunistic Infection, Cancer/Oncology |
|
|
Automated Density Measures for Estimating Breast Cancer Risk and Therapy Response |
Karla Kerlikowske, MD |
Cancer/Oncology |
|
|
Influencing cervical cancer prevention and detection online through social media |
Urmimala Sarkar, MD |
Cancer/Oncology, Women's Health |
|
|
Exposomic approach to understand the effect of immigration and genetic ancestry on breast cancer risk in U.S. Latinas |
Laura Fejerman, PhD |
Cancer/Oncology, Occupational and Environmental Disease |
|
|
Mechanism regulating ErbB signaling network in head and neck cancer |
Randall Kramer, PhD |
Cancer/Oncology, Immunology |
|
|
Modeling to Improve Prostate Cancer Outcomes Across Diverse Populations |
Matthew Cooperberg, MD |
Cancer/Oncology, Pharmacology and Drug Treatment |
|
|
Evaluating a Community-Driven Cervical Cancer Prevention program in Western Kenya |
Robert Hiatt, MD, PhD |
Cancer/Oncology |
|
|
UCSF CT Radiation Dose Registry to Ensure a Patient Centered Approach for Imaging |
Rebecca Smith-Bindman, MD |
Cancer/Oncology, Epidemiology and Surveillance, Risk Reduction and Prevention |
|
|
A Biophysical Perspective of Breast Cancer Metastasis and Treatment Resistance |
Valerie Weaver, PhD |
Cancer/Oncology, Women's Health |
|
|
Elucidating the molecular and contextual basis for IDLE ultralow risk lesions and the tumor immune microenvironment of high risk in situ and invasive breast cancers |
Laura Esserman, MD |
Cancer/Oncology, Women's Health |
|
|
Targeting KRAS Mutant Lung Cancers |
Frank McCormick, PhD, FRS |
Cancer/Oncology |
|
|
Prostate Cancer Foundation Young Investigator Award |
|
Cancer/Oncology, Residencies, Fellowships, and Postdoctoral Training |
|
|
Hepatitis C Therapeutic Registry and Research Network (HCV-TARGET) |
Kathleen Tebb, PhD |
Infectious Disease, Cancer/Oncology |
|
|
Testing Targeted Therapy in Philadelphia Chromosome-Like (Ph-Like) All |
Mignon Loh, MD |
Cancer/Oncology, Drug and Diagnostics Development |
|
|
A Novel Targeted Therapy for Medulloblastoma |
Jeremy Reiter, MD, PhD |
Cancer/Oncology |
|
|
A Randomized Phase 2 Trial of Immediate vs. Delayed Anti-Ctla4 Blockade Following Sipuleucel-T Treatment for Prostate Cancer Immunotherapy |
Lawrence Fong, MD |
Cancer/Oncology, Pharmacology and Drug Treatment |
|
|